Cargando…
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?
[Figure: see text]
Autores principales: | Cadrin-Tourigny, Julia, Krahn, Andrew D, Saba, Magdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202496/ https://www.ncbi.nlm.nih.gov/pubmed/37213070 http://dx.doi.org/10.1093/europace/euad132 |
Ejemplares similares
-
Subcutaneous ICD Implantation and Catheter Ablation: A Step-Planned Approach for Ventricular Tachycardia Management in ARVC
por: Sanniti, Aurora, et al.
Publicado: (2022) -
Intrinsic anti-tachycardia pacing terminated ventricular tachycardia resistant to traditional anti-tachycardia pacing
por: Hagiwara, Hikaru, et al.
Publicado: (2022) -
Transvenous Phrenic Nerve Stimulation: A Novel Therapy Gathering Pace
por: Morris, Idunn S., et al.
Publicado: (2022) -
Transvenous lead extraction in conduction system pacing
por: Wijesuriya, Nadeev, et al.
Publicado: (2022) -
Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion
por: Honarbakhsh, Shohreh, et al.
Publicado: (2023)